Evidence map›Paper›PMID 38519771›Full record

ArticleCell death and differentiation2024

Mitophagy mediated by BNIP3 and NIX protects against ferroptosis by downregulating mitochondrial reactive oxygen species.

Shun-Ichi Yamashita, Yuki Sugiura, Yuta Matsuoka, Rae Maeda, Keiichi Inoue, Kentaro Furukawa, Tomoyuki Fukuda, David C Chan, Tomotake Kanki

Open access · greenAbstract read
In one paragraph

Article in Cell death and differentiation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
44.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 116 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Shun-Ichi YamashitaDepartment of Cellular Physiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 950-8510, Japan. yamash@med.niigata-u.ac.jp.ORCID 0000-0001-8892-0765
Yuki SugiuraCenter for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.
Yuta MatsuokaCenter for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.
Rae MaedaCenter for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.
Keiichi InoueDepartment of Cellular Physiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 950-8510, Japan.
Kentaro FurukawaDepartment of Cellular Physiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 950-8510, Japan.
Tomoyuki FukudaDepartment of Cellular Physiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 950-8510, Japan.ORCID 0000-0003-2069-7127
David C ChanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, 91125, USA.ORCID 0000-0002-0191-2154
Tomotake KankiDepartment of Cellular Physiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 950-8510, Japan. kanki@med.niigata-u.ac.jp.ORCID 0000-0001-9646-5379
Niigata University · JPKyoto University · JPCalifornia Institute of Technology · US

Funding

Homeostatic Mechanisms Regulating Mitochondrial Health EQUIPMENT SUPPLEMENTR35GM127147 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI David C Chan · 2018 to 2026
$6.0M
Japan Agency for Medical Research and Development (AMED) JP21gm6110013Japan Agency for Medical Research and Development (AMED) JP23ek0109647Japan Agency for Medical Research and Development (AMED) JP23gm1710006MEXT | Japan Society for the Promotion of Science (JSPS) 16KK0162MEXT | Japan Society for the Promotion of Science (JSPS) 18H04691MEXT | Japan Society for the Promotion of Science (JSPS) 18H04858MEXT | Japan Society for the Promotion of Science (JSPS) 19H05712MEXT | Japan Society for the Promotion of Science (JSPS) 22K07207NIGMS NIH HHS R35 GM127147
6 · The paper itself

Abstract

Mitophagy plays an important role in the maintenance of mitochondrial homeostasis and can be categorized into two types: ubiquitin-mediated and receptor-mediated pathways. During receptor-mediated mitophagy, mitophagy receptors facilitate mitophagy by tethering the isolation membrane to mitochondria. Although at least five outer mitochondrial membrane proteins have been identified as mitophagy receptors, their individual contribution and interrelationship remain unclear. Here, we show that HeLa cells lacking BNIP3 and NIX, two of the five receptors, exhibit a complete loss of mitophagy in various conditions. Conversely, cells deficient in the other three receptors show normal mitophagy. Using BNIP3/NIX double knockout (DKO) cells as a model, we reveal that mitophagy deficiency elevates mitochondrial reactive oxygen species (mtROS), which leads to activation of the Nrf2 antioxidant pathway. Notably, BNIP3/NIX DKO cells are highly sensitive to ferroptosis when Nrf2-driven antioxidant enzymes are compromised. Moreover, the sensitivity of BNIP3/NIX DKO cells is fully rescued upon the introduction of wild-type BNIP3 and NIX, but not the mutant forms incapable of facilitating mitophagy. Consequently, our results demonstrate that BNIP3 and NIX-mediated mitophagy plays a role in regulating mtROS levels and protects cells from ferroptosis.

Indexed as

FerroptosisMembrane ProteinsMitochondriaMitophagyProto-Oncogene ProteinsReactive Oxygen SpeciesDown-RegulationHeLa CellsHumansMitochondrial ProteinsNF-E2-Related Factor 2Tumor Suppressor ProteinsBNIP3L protein, humanBNIP3 protein, humanMembrane ProteinsMitochondrial ProteinsNF-E2-Related Factor 2Proto-Oncogene ProteinsReactive Oxygen SpeciesTumor Suppressor Proteins

Identifiers

PMID38519771
PMCPMC11094013
OpenAlexW4393078422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.